Author Topic: The FDA’s 2096 FOIA Gambit  (Read 65 times)

0 Members and 1 Guest are viewing this topic.

Offline Elderberry

  • TBR Contributor
  • *****
  • Posts: 24,772
The FDA’s 2096 FOIA Gambit
« on: December 10, 2021, 11:20:22 pm »
The Post & Email by Joseph DeMaio 12/10/2021

"SOMETHING IS ROTTEN IN THE STATE OF DENMARK"

There is an interesting Freedom of Information Act (“FOIA”) lawsuit pending in U.S. District Court in Dallas, Texas.  The lawsuit is brought by a private, non-profit organization, the “Public Health and Medical Professionals for Transparency” (“PHMPT”).

The suit seeks documents from the federal Food and Drug Administration (“FDA”) relating to its August 23, 2021 “approval” of the Biologics License Application (“BLA”) for a so-called COVID-19 “vaccine” produced by Pfizer, Inc. – in collaboration with the actual license applicant, BioNTech Manufacturing GmbH – discussed and commented upon here.

Under the FOIA, there are certain provisions allowing for the redaction or “masking” of information for a variety of reasons (e.g., personal safety, legal confidentiality, national security, etc.).  In responding to the PHMPT FOIA request, the FDA has refused to expedite its disclosure obligations, claiming that the mountain range – not merely a mountain – of documents at issue may need to be examined page-by-page, line-by-line for redaction purposes.

That task, the FDA originally claimed, would take 55 years, or until 2076.  The FDA wanted the court to ratify that timeline for compliance with the FOIA request.  Upon further consideration, however, the FDA has now revised its estimate of how long it will take to complete the task: 75 years, or until 2096.

More: https://www.thepostemail.com/2021/12/10/the-fdas-2096-foia-gambit/